Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands von Stevanovic, J, Pompen, M, Le, H.H, Rozenbaum, M.H, Postma, M.J

Volltext

Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands von van Haalen, H.G.M, Pompen, M, Bergenheim, K, McEwan, P, Townsend, R, Roudaut, M

Volltext

EE309 Cost-Effectiveness of Mavacamten for the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy in the Netherlands von Buisman, L., Treur, M., Verkaik, M., Van De Wetering, G., Pronk, L.M., Pompen, M., Hurst, M.

Volltext

PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Real-World Population Based Study von Blommestein, H, Issa, D, Pompen, M, Révil, C, Hoogendoorn, M, Joosten, P, Huijgens, P, Uyl-de Groot, C

Volltext

EE302 Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Unresectable Malignant Pleural Mesothelioma (uMPM) in the Netherlands von Daumont, MJ, Torkilseng, E, Pompen, M, Stevanovic, J, Stawowczyk, E

Volltext

PMS49 Cost-Effectiveness of Rituximab in the Treatment of RA Patients in the Netherlands von Diamantopoulos, A, Kievit, W, De Vries, R, Pompen, M

Volltext

PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis Patients von LeReun, C, Neophytou, I, De Vries, R, Diamantopoulos, A, Pompen, M

Volltext

EE383 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Nivolumab Monotherapy (NIVO) for Patients With Advanced Melanoma in the Netherlands von Foo, J., Najlerahim, S., McDonald, L., Stevanovic, J., Pompen, M., Roberts, S., Baginska, B., Tokarz, A., de Lacey, T., Novak, A.

Volltext

PCN190 - COST-EFFECTIVENESS OF NIVOLUMAB + IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC RENAL CELL CARCINOMA IN THE NETHERLANDS von Klijn, S., Van de Wetering, G., Malcolm, B., Dale, P., Pompen, M., Stevanovic, J.

Volltext

PCV103 - Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands von Stevanovic, J., Pompen, M., Le, H.H., Rozenbaum, M.H., Postma, M.J.

Volltext

PDB57 - Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands von van Haalen, H.G.M., Pompen, M., Bergenheim, K., McEwan, P., Townsend, R., Roudaut, M.

Volltext

PCN109 COST-EFFECTIVENESS OF RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE DUTCH SETTING von Pompen, M, ten Hoor, G, Carr, E, Aultman, R

Volltext

CN3 PHARMACOECONOMIC (PE) ANALYSIS OF THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN THE NETHERLANDS DEMONSTRATES THAT ERLOTINIB DOMINATES DOCETAXEL AND IS COST-EFFECTIVE O... von Pompen, M, Novak, A, Postmus, P, Gok, M, Gyldmark, M

Volltext

MD2 ECONOMIC CONSEQUENCES OF PROVIDING RITUXIMAB AS ATREATMENT ALTERNATIVE FOR RHEUMATOID ARTHRITIS IN THE NETHERLANDS von Pompen, M, Diamantopoulos, A, Kievit, W, Moers, R, Kielhorn, A

Volltext

Airway epithelial cell mediators induce differentiation of an immature mast cell line von Pompen, M

Volltext

MO4 TRANSFERABILITY OF MODEL-BASED ECONOMIC EVALUATIONS: THE CASE OF TRASTUZUMAB FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE NETHERLANDS von Joore, MA, Tjan Heijnen, V, Severens, JL, Novák, A, Oron, U, Pompen, M, Essers, BA

Volltext

PCN41 ECONOMIC EVALUATION OF TRASTUZUMAB FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE EARLY BREAST CANCER IN THE NETHERLANDS von Essers, BA, Tjan Heijnen, V, Severens, JL, Novák, A, Oron, U, Pompen, M, Joore, MA

Volltext

Lung epithelial H292 cells induce differentiation of immature human HMC-1 mast cells by interleukin-6 and stem cell factor von POMPEN, M, SMIDS, B. S, DINGEMANS, K. P, JANSEN, H. M, OUT, T. A, LUTTER, R

Volltext

Products from human mast cell line cells enhance the production of interferon‐γ by CD8+ and CD4+ T cells von De Pater‐Huijsen, Francina L., De Riemer, MariËlle J., Reijneke, Richard M. R., Pompen, Marjolein, Lutter, René, Jansen, Henk M., Out, Theo A.

Volltext

Products from human mast cell line cells enhance the production of interferon- gamma by CD8 super(+) and CD4 super(+) T cells von De Pater-Huijsen, FL, De Riemer, MJ, Reijneke, RMR, Pompen, M, Lutter, R, Jansen, H M, Out, T A

Volltext